CCN2 and lymphoma: In lymphoma cells, S1P treatment showed that YAP could not be phosphorylated but translocated to nucleus, as evident by the decreased phosphorylated-YAP and increased YAP target gene CTGF, while blockage of S1P receptors significantly increased phosphorylated-YAP and inhibited the S1P-induced cell proliferation and migration.